Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS)

Autoimmune lymphoproliferative syndrome (ALPS) is caused by germline or somatic loss of function FAS mutations resulting in impaired apoptosis and consequent expansion of T-lymphocytes causing organomegaly and autoimmune anemia, neutropenia and thrombocytopenia. Herein, we report on a case of dissem...

Full description

Bibliographic Details
Main Authors: Andrea Lisco, Chun-Shu Wong, Susan Price, Peiying Ye, Julie Niemela, Megan Anderson, Elizabeth Richards, Maura Manion, Harry Mystakelis, Morgan Similuk, Bernice Lo, Jennifer Stoddard, Sergio Rosenzweig, Christophe Vanpouille, Adam Rupert, Irina Maric, Ainhoa Perez-Diez, David Parenti, Peter D. Burbelo, V. Koneti Rao, Irini Sereti
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.01193/full
id doaj-318ffdda9a354f6e903f114e3add0309
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Andrea Lisco
Chun-Shu Wong
Susan Price
Peiying Ye
Julie Niemela
Megan Anderson
Elizabeth Richards
Maura Manion
Harry Mystakelis
Morgan Similuk
Bernice Lo
Jennifer Stoddard
Sergio Rosenzweig
Christophe Vanpouille
Adam Rupert
Irina Maric
Ainhoa Perez-Diez
David Parenti
Peter D. Burbelo
V. Koneti Rao
Irini Sereti
spellingShingle Andrea Lisco
Chun-Shu Wong
Susan Price
Peiying Ye
Julie Niemela
Megan Anderson
Elizabeth Richards
Maura Manion
Harry Mystakelis
Morgan Similuk
Bernice Lo
Jennifer Stoddard
Sergio Rosenzweig
Christophe Vanpouille
Adam Rupert
Irina Maric
Ainhoa Perez-Diez
David Parenti
Peter D. Burbelo
V. Koneti Rao
Irini Sereti
Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS)
Frontiers in Immunology
CD4 lymphopenia
follicular T helper cells
ALPS-FAS
autoimmune cytopenia
apoptosis
author_facet Andrea Lisco
Chun-Shu Wong
Susan Price
Peiying Ye
Julie Niemela
Megan Anderson
Elizabeth Richards
Maura Manion
Harry Mystakelis
Morgan Similuk
Bernice Lo
Jennifer Stoddard
Sergio Rosenzweig
Christophe Vanpouille
Adam Rupert
Irina Maric
Ainhoa Perez-Diez
David Parenti
Peter D. Burbelo
V. Koneti Rao
Irini Sereti
author_sort Andrea Lisco
title Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS)
title_short Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS)
title_full Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS)
title_fullStr Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS)
title_full_unstemmed Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS)
title_sort paradoxical cd4 lymphopenia in autoimmune lymphoproliferative syndrome (alps)
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2019-05-01
description Autoimmune lymphoproliferative syndrome (ALPS) is caused by germline or somatic loss of function FAS mutations resulting in impaired apoptosis and consequent expansion of T-lymphocytes causing organomegaly and autoimmune anemia, neutropenia and thrombocytopenia. Herein, we report on a case of disseminated varicella zoster infection after post-partum vaccination in a patient found to have CD4 lymphopenia and eventually diagnosed with ALPS caused by a novel germline missense mutation in FAS death-domain. A subsequent retrospective analysis of 169 patients of the NIH ALPS-FAS cohort, revealed that CD4-T-cells lymphopenia (< 300 cells/μl) may occur in 5% of ALPS-FAS patients irrespectively of the underlying genetic defect, organomegaly or immunosuppressive treatment. Although immunophenotyping did not show depletion of specific CD4-T-cells subpopulations, CD4-lymphopenic ALPS-FAS subjects had an expansion of a subset of circulating T-follicular-helper (cTfh) cells, associated with autoantibody production (CCR7lowPD-1high). Furthermore, autoantibodies binding on CD4-T-cells were detected in 50% of the CD4-lymphopenic ALPS-FAS patients and caused cytotoxicity in a natural killer (NK)-mediated antibody-dependent-cellular cytotoxicity assay. Such autoantibodies can therefore be associated with CD4-T-cell death, impaired activation induced proliferation or impaired trafficking. The expansion of autoreactive T-cells in ALPS-FAS is known to be associated with autoimmune clinical manifestations, however our study reveals that ALPS-FAS can also be associated with a paradoxical depletion of CD4-T-cells due to the presence of autoantibodies on the surface of CD4-T-cells which can in turn result in increased susceptibility to opportunistic infections. These novel findings have implications for the diagnosis, clinical monitoring, and management of patients with ALPS-FAS.
topic CD4 lymphopenia
follicular T helper cells
ALPS-FAS
autoimmune cytopenia
apoptosis
url https://www.frontiersin.org/article/10.3389/fimmu.2019.01193/full
work_keys_str_mv AT andrealisco paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT chunshuwong paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT susanprice paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT peiyingye paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT julieniemela paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT megananderson paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT elizabethrichards paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT mauramanion paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT harrymystakelis paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT morgansimiluk paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT bernicelo paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT jenniferstoddard paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT sergiorosenzweig paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT christophevanpouille paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT adamrupert paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT irinamaric paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT ainhoaperezdiez paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT davidparenti paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT peterdburbelo paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT vkonetirao paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
AT irinisereti paradoxicalcd4lymphopeniainautoimmunelymphoproliferativesyndromealps
_version_ 1725178683801468928
spelling doaj-318ffdda9a354f6e903f114e3add03092020-11-25T01:09:27ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-05-011010.3389/fimmu.2019.01193450664Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS)Andrea Lisco0Chun-Shu Wong1Susan Price2Peiying Ye3Julie Niemela4Megan Anderson5Elizabeth Richards6Maura Manion7Harry Mystakelis8Morgan Similuk9Bernice Lo10Jennifer Stoddard11Sergio Rosenzweig12Christophe Vanpouille13Adam Rupert14Irina Maric15Ainhoa Perez-Diez16David Parenti17Peter D. Burbelo18V. Koneti Rao19Irini Sereti20Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United StatesLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United StatesLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United StatesLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United StatesImmunology Service, Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD, United StatesLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United StatesLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United StatesLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United StatesLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United StatesClinical Genomics Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United StatesLaboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United StatesImmunology Service, Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD, United StatesImmunology Service, Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD, United StatesProgram in Physical Biology, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United StatesAIDS Monitoring Laboratory, Leidos Biomedical Research, Frederick, MD, United StatesHematology Service, Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD, United StatesLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United StatesGeorge Washington University Medical Center, Washington, DC, United States0Dental Clinical Research Core, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, United StatesLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United StatesLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United StatesAutoimmune lymphoproliferative syndrome (ALPS) is caused by germline or somatic loss of function FAS mutations resulting in impaired apoptosis and consequent expansion of T-lymphocytes causing organomegaly and autoimmune anemia, neutropenia and thrombocytopenia. Herein, we report on a case of disseminated varicella zoster infection after post-partum vaccination in a patient found to have CD4 lymphopenia and eventually diagnosed with ALPS caused by a novel germline missense mutation in FAS death-domain. A subsequent retrospective analysis of 169 patients of the NIH ALPS-FAS cohort, revealed that CD4-T-cells lymphopenia (< 300 cells/μl) may occur in 5% of ALPS-FAS patients irrespectively of the underlying genetic defect, organomegaly or immunosuppressive treatment. Although immunophenotyping did not show depletion of specific CD4-T-cells subpopulations, CD4-lymphopenic ALPS-FAS subjects had an expansion of a subset of circulating T-follicular-helper (cTfh) cells, associated with autoantibody production (CCR7lowPD-1high). Furthermore, autoantibodies binding on CD4-T-cells were detected in 50% of the CD4-lymphopenic ALPS-FAS patients and caused cytotoxicity in a natural killer (NK)-mediated antibody-dependent-cellular cytotoxicity assay. Such autoantibodies can therefore be associated with CD4-T-cell death, impaired activation induced proliferation or impaired trafficking. The expansion of autoreactive T-cells in ALPS-FAS is known to be associated with autoimmune clinical manifestations, however our study reveals that ALPS-FAS can also be associated with a paradoxical depletion of CD4-T-cells due to the presence of autoantibodies on the surface of CD4-T-cells which can in turn result in increased susceptibility to opportunistic infections. These novel findings have implications for the diagnosis, clinical monitoring, and management of patients with ALPS-FAS.https://www.frontiersin.org/article/10.3389/fimmu.2019.01193/fullCD4 lymphopeniafollicular T helper cellsALPS-FASautoimmune cytopeniaapoptosis